New China-based biotechs fueling growth in manufacturing across China9 Apr 2019
New guidelines will see poorer quality manufacturers drop out of the market.
A key trend to emerge at this year's CPhI & P-MEC China is the rise in the number of innovative China-based biotechs. This, coupled with the easing of regulatory pathways and an emerging CDMO sector, is fueling significant growth in manufacturing across China. In view of this, experts at the event will assess the Marketing Authorization Holder (MAH) Pilot Program, as well as recent reforms of China’s regulatory landscape and the opportunities for international pharma.
CPhI & P-MEC China – co-organized by UBM EMEA, CCCMHPIE, and UBM Sinoexpo – takes place at the Shanghai New International Expo Center (SNIEC) on 18-20 June 2019. The event will be co-located with ICSE, InnoPack, bioLIVE, NEX, Labworld, FDF, and EP & Clean Tech. Seen as the bellwether of pharmaceutical trends across the country, CPhI & P-MEC China’s agenda is packed with content from over 100 onsite conferences and activities as well as more than 50 seminars, with speakers from China and abroad.
With the Chinese pharma growing at a ferocious pace, CPhI & P-MEC China is expected to welcome 70,000 attendees in its 19th edition – a year-on-year increase of 55% – which is further indicative of the buoyancy of the Chinese market. The event is also expected to see a 6% increase in exhibitors, with more than 3,200 from over 120 countries in attendance.
“China is issuing new guidelines at a feverish pace and will be harmonized with ICH very quickly. The result is that over the next 2 to 3 years poorer quality manufacturers will drop out of the market and China’s manufacturers will look to compete in international markets as well as domestic,” CPhI Annual Report Expert, Bikash Chatterjee on outlook of 2019.
Wider market data also supports this ongoing boom, with China's pharmaceutical market projected to grow strongly from $115.2 billion in 2016 to $159.4 billion by 2021 and $234.2 billion by 2026. This represents a 10-year compound annual growth rate of 8.8% in local currency terms and 7.3% in US dollar terms. Similarly, bioprocessing in China has been on a trajectory of rapid growth, with a 39% growth in facilities, and total capacity is growing ≥8% annually, with biosimilars offering the largest growth potential.
At the 2019 edition, for the first time, CPhI & P-MEC China will launch bioLIVE – their new bioprocessing and manufacturing exhibition – which has evolved from the previous BioPh China and will run adjacent. This exposition is in response to the large molecule trend within the industry, and arrives at a particularly prominent moment. Within the last year, there has been a proliferation of biosimilars and double-digit approvals of biologics – as well as a host of investments taking place in contract services.
Marie Lagrenee, Brand Manager at CPhI & P-MEC China, commented: “The growth of the Chinese pharma economy has been exponential in recent years, with regulatory reforms spearheading the increased interest in the region from both domestic and international companies. With a bourgeoning CDMO sector and recent harmonization by ICH, it’s pivotal that events such as CPhI & P-MEC China provide a platform to drive growth, exchange new ideas and expedite new deals to help nurture this budding market.”
The third edition of China Pharma Week will take place alongside CPhI & P-MEC China, 17–21 June 2019 focusing on Leadership, Business, Networking, Innovation, Recognition and Knowledge. Activities will include plant visits, a networking dinner, women in leadership forum, summits and the Innovation Gallery Tours, giving a deeper work floor insight and dedicated industry conferences on different sectors.
BASF launches three new active ingredients derived from the rambutan tree
2 Apr 2019
The ingredients are extracted from the first organically certified rambutan gardens in Vietnam.Read more
Japanese R&D reinvigorated with international partnerships proliferating
26 Mar 2019
Generics consumption increasing, and the removal of long-list products is opening up funding towards true innovation.Read more
Sizeable growth potential for global drug delivery and packaging in 2019
19 Mar 2019
Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019.Read more
Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy
13 Mar 2019
Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.Read more
Overcoming lyophilization challenges at Interphex 2019
10 Mar 2019
Line of Sight approach to freeze-drying enables organizations to bring pharmaceutical products safely and quickly to market.Read more
'Tamper-evident' benefits are evident
28 Feb 2019
2019 will mark Uniplast's debut at this year's edition of CPhI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging.Read more
Japan solid dose market predicted to bloom in 2019
21 Feb 2019
Executives predict Japan to be the second fastest growing mature market for solid dose drugs in 2019, and the second fastest overall country for biologicals growth.Read more
Pharma in South East Asia booming as CPhI opens event for the first time in Thailand
27 Feb 2019
Healthcare and pharmaceutical reforms, designed to increase access to high-value medicines, driving growth.Read more
Pharmapack Europe 2019 Award Winners
7 Feb 2019
Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.Read more
Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering
27 Jan 2019
New report highlights Germany, France and Switzerland as tier-one nations for ‘drug delivery innovation’, and warns the challenge will be to scale-up and approve promising prototypes.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation